Abbott Laboratories (ABT)vsNational Grid PLC ADR (NGG)
ABT
Abbott Laboratories
$91.07
+0.56%
HEALTHCARE · Cap: $151.49B
NGG
National Grid PLC ADR
$81.86
-0.33%
UTILITIES · Cap: $80.25B
Smart Verdict
WallStSmart Research — data-driven comparison
Abbott Laboratories generates 155% more annual revenue ($45.13B vs $17.69B). NGG leads profitability with a 18.3% profit margin vs 13.9%. NGG appears more attractively valued with a PEG of 1.00. NGG earns a higher WallStSmart Score of 62/100 (C+).
ABT
Buy56
out of 100
Grade: C
NGG
Buy62
out of 100
Grade: C+
Intrinsic Value Comparison
Multi-model valuation · Graham Formula
Margin of Safety
-28.5%
Fair Value
$70.89
Current Price
$91.07
$20.18 premium
Intrinsic value data unavailable for NGG.
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Large-cap with strong market position
Strong operational efficiency at 32.6%
Large-cap with strong market position
Growing faster than its price suggests
Areas to Watch
Earnings declined 19.7%
Trading at 8.2x book value
2.0% revenue growth
Elevated debt levels
Weak financial health signals
Comparative Analysis Report
WallStSmart ResearchBull Case : ABT
The strongest argument for ABT centers on Market Cap. PEG of 1.30 suggests the stock is reasonably priced for its growth.
Bull Case : NGG
The strongest argument for NGG centers on Operating Margin, Market Cap, PEG Ratio. Profitability is solid with margins at 18.3% and operating margin at 32.6%. PEG of 1.00 suggests the stock is reasonably priced for its growth.
Bear Case : ABT
The primary concerns for ABT are EPS Growth.
Bear Case : NGG
The primary concerns for NGG are Price/Book, Revenue Growth, Debt/Equity.
Key Dynamics to Monitor
ABT carries more volatility with a beta of 0.65 — expect wider price swings.
ABT is growing revenue faster at 7.8% — sustainability is the question.
ABT generates stronger free cash flow (916M), providing more financial flexibility.
Monitor MEDICAL DEVICES industry trends, competitive dynamics, and regulatory changes.
Bottom Line
NGG scores higher overall (62/100 vs 56/100), backed by strong 18.3% margins. Both earn "Buy" and "Buy" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
Abbott Laboratories
HEALTHCARE · MEDICAL DEVICES · USA
Abbott Laboratories is an American multinational medical devices and health care company with headquarters in Abbott Park, Illinois, United States. The company was founded by Chicago physician Wallace Calvin Abbott in 1888 to formulate known drugs; today, it sells medical devices, diagnostics, branded generic medicines and nutritional products. It split off its research-based pharmaceuticals business into AbbVie in 2013.
Visit Website →National Grid PLC ADR
UTILITIES · UTILITIES - REGULATED ELECTRIC · USA
National Grid plc transmits and distributes electricity and natural gas. The company is headquartered in London, the United Kingdom.
Visit Website →Compare with Other MEDICAL DEVICES Stocks
Want to dig deeper into these stocks?